Landec Corporation was incorporated in California on October 31, 1986 and reincorporated as a Delaware corporation on November 6, 2008. The Company and its subsidiaries design, develop, manufacture and market differentiated products in food and biomaterials markets and license technology applications to partners. Its segments consists of the Food Products Technology segment, the Food Export segment and the Hyaluronan-based Biomaterials segment. Its geographical areas include Canada, Taiwan, Indonesia, China, Japan, Belgium and among others. It competes with large food processors, packaging companies, and medical and pharmaceutical companies are intense. The Company has approximately 48 U.S. patents. The Company is subject to extensive and rigorous regulation by the FDA, which regulates some of the products as medical devices and which, in some cases, requires Pre-Market Approval (PMA), and by foreign countries, which regulate some of the products as medical devices or drugs.